Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as azacitidine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Interferon alfa may interfere with the growth of tumor cells. Giving azacitidine together
with interferon alfa may be an effective treatment for melanoma.
PURPOSE: This phase I trial is studying the side effects and best dose of azacitidine when
given together with interferon alfa in treating patients with metastatic melanoma.